Year: 2024

Gesamtstimmrechte | 12 März 2024 08:51 Epigenomics AG / Total Voting Rights Announcement Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 12.03.2024 / 08:51 CET/CEST Total Voting Rights Announcement transmitted by EQS News – a service of EQS Group AG. The issuer […]

Vorabbekanntmachung | 6 März 2024 09:22 Epigenomics AG / Preliminary announcement on the disclosure of financial statements Epigenomics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] 06.03.2024 / 09:22 CET/CEST Preliminary announcement of the publication of financial reports according to Articles […]

EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet 15.02.2024 / 10:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet Berlin, February 15, 2024 – Epigenomics AG (Frankfurt General […]

EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board 31.01.2024 / 15:30 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board Berlin, January 31, […]

EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Resignation of Supervisory Board Member Dr Heikki Lanckriet (PhD) 26.01.2024 / 13:16 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Resignation of Supervisory Board Member Dr Heikki Lanckriet (PhD) Berlin, Germany, January 26, 2024 – Dr Heikki Lanckriet (PhD) has informed the competent bodies of Epigenomics AG […]